nadofaragene firadenovec-vncg

View Patient Information

A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, nadofaragene firadenovec-vncg infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	nadofaragene firadenovec nadofaragene firadenovec/Syn3 recombinant adenovirus-interferon SCH 721015 recombinant adenovirus-interferon with Syn3 recombinant adenovirus-interferon/Syn3
US brand name:	Adstiladrin
Abbreviation:	rAd-IFN rAd-IFN-2b rAd-IFN/Syn3
Code name:	SCH 721015

nadofaragene firadenovec-vncg

Search NCI's Drug Dictionary